Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 1
2021 2
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Incidence, risk factors and outcome of acute kidney injury in critically ill COVID-19 patients in Tyrol, Austria: a prospective multicenter registry study.
Mayerhöfer T, Perschinka F, Klein SJ, Peer A, Lehner GF, Bellmann R, Gasteiger L, Mittermayr M, Breitkopf R, Eschertzhuber S, Mathis S, Fiala A, Fries D, Ströhle M, Foidl E, Hasibeder W, Helbok R, Kirchmair L, Stögermüller B, Krismer C, Heiner T, Ladner E, Thomé C, Preuß-Hernandez C, Mayr A, Potocnik M, Reitter B, Brunner J, Zagitzer-Hofer S, Ribitsch A, Joannidis M. Mayerhöfer T, et al. Among authors: ribitsch a. J Nephrol. 2023 Dec;36(9):2531-2540. doi: 10.1007/s40620-023-01760-3. Epub 2023 Oct 14. J Nephrol. 2023. PMID: 37837501 Free PMC article.
Safety of interhospital transfer for critically ill COVID-19 patients.
Perschinka F, Niedermoser H, Peer A, Lehner GF, Mayerhöfer T, Stöllnberger V, Fries D, Joannidis M; Collaborators. Perschinka F, et al. Crit Care. 2023 Nov 23;27(1):456. doi: 10.1186/s13054-023-04735-9. Crit Care. 2023. PMID: 37996945 Free PMC article. No abstract available.
Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.
Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, Rami-Merhar B, Steigleder-Schweiger C, Graninger W, Borkenstein M, Pieber TR. Treiber G, et al. Among authors: ribitsch a. Clin Immunol. 2015 Dec;161(2):217-24. doi: 10.1016/j.clim.2015.08.002. Epub 2015 Aug 12. Clin Immunol. 2015. PMID: 26277548 Clinical Trial.
Changes in characteristics and outcomes of critically ill COVID-19 patients in Tyrol (Austria) over 1 year.
Mayerhöfer T, Klein SJ, Peer A, Perschinka F, Lehner GF, Hasslacher J, Bellmann R, Gasteiger L, Mittermayr M, Eschertzhuber S, Mathis S, Fiala A, Fries D, Kalenka A, Foidl E, Hasibeder W, Helbok R, Kirchmair L, Stögermüller B, Krismer C, Heiner T, Ladner E, Thomé C, Preuß-Hernandez C, Mayr A, Pechlaner A, Potocnik M, Reitter B, Brunner J, Zagitzer-Hofer S, Ribitsch A, Joannidis M. Mayerhöfer T, et al. Among authors: ribitsch a. Wien Klin Wochenschr. 2021 Dec;133(23-24):1237-1247. doi: 10.1007/s00508-021-01945-5. Epub 2021 Oct 18. Wien Klin Wochenschr. 2021. PMID: 34661740 Free PMC article.